NCT01532154View on ClinicalTrials.gov

Fampridine Pregnancy Exposure Registry

TerminatedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Multiple SclerosisPregnancy

Interventions

DRUG

Fampridine

As prescribed and taken after the last menstrual period prior to becoming pregnant or anytime during the pregnancy

Trial Locations (1)

75013

Hopital Pitie Salpetriere, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY